
Pharmaceutical Executive-06-01-2008
Advertisement
Advertisement
Trending on PharmExec
1
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
2
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
3
Pharmaceutical Executive Daily: Carvykti Demonstrates Sustained Remissions
4
Carvykti Displays Sustained Remissions in Early Use for Relapsed or Refractory Multiple Myeloma
5








